NCT00561197 2013-01-04
An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
Ascenta Therapeutics
Phase 1/2 Terminated
Clinical Trials
1 trialsLocally Advanced Esophageal or GE Junction Cancer × gossypol acetic acid × Gastrointestinal × Clear all